Free Trial
→ Rent out your stocks? (From Profits Run) (Ad)tc pixel Free TLM Stock Alerts

Talisman Metals (TLM) Competitors

GBX 9 +0.50 (+5.88%)
As of 10/13/2026 11:22 AM Eastern
Compare

TLM vs. AOR, IXI, SBTX, OBD, and FAB

Should you buy Talisman Metals stock or one of its competitors? Talisman Metals's main competitors and comparable companies include AorTech International (AOR), IXICO (IXI), SkinBioTherapeutics (SBTX), Oxford BioDynamics (OBD), and Fusion Antibodies (FAB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Talisman Metals compare to AorTech International?

AorTech International (LON:AOR) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Company Net Margins Return on Equity Return on Assets
AorTech InternationalN/A N/A N/A
Talisman Metals N/A N/A 3.70%

1.4% of Talisman Metals shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, AorTech International's average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
AorTech International Neutral
Talisman Metals Neutral

AorTech International has higher revenue and earnings than Talisman Metals. AorTech International is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AorTech International£539K0.00N/A-£3.70N/A
Talisman MetalsN/AN/A-£1.35M£12.390.73

Summary

Talisman Metals beats AorTech International on 5 of the 6 factors compared between the two stocks.

How does Talisman Metals compare to IXICO?

Talisman Metals (LON:TLM) and IXICO (LON:IXI) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, media sentiment, earnings, profitability, risk and dividends.

Talisman Metals has higher earnings, but lower revenue than IXICO. IXICO is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.73
IXICO£7.28M2.27-£3.58M-£1.95N/A

Talisman Metals has a beta of 0.9, suggesting that its share price is 10% less volatile than the broader market. Comparatively, IXICO has a beta of 0.106, suggesting that its share price is 89% less volatile than the broader market.

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 30.6% of IXICO shares are held by institutional investors. 95.2% of Talisman Metals shares are held by company insiders. Comparatively, 3.1% of IXICO shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Talisman Metals has a net margin of 0.00% compared to IXICO's net margin of -24.98%. Talisman Metals' return on equity of 0.00% beat IXICO's return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
IXICO -24.98%-16.18%-10.40%

In the previous week, IXICO had 1 more articles in the media than Talisman Metals. MarketBeat recorded 1 mentions for IXICO and 0 mentions for Talisman Metals. IXICO's average media sentiment score of 0.67 beat Talisman Metals' score of 0.00 indicating that IXICO is being referred to more favorably in the news media.

Company Overall Sentiment
Talisman Metals Neutral
IXICO Positive

Summary

Talisman Metals beats IXICO on 8 of the 12 factors compared between the two stocks.

How does Talisman Metals compare to SkinBioTherapeutics?

Talisman Metals (LON:TLM) and SkinBioTherapeutics (LON:SBTX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, valuation, dividends and risk.

Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market. Comparatively, SkinBioTherapeutics has a beta of 0.104, meaning that its share price is 90% less volatile than the broader market.

In the previous week, Talisman Metals' average media sentiment score of 0.00 equaled SkinBioTherapeutics'average media sentiment score.

Company Overall Sentiment
Talisman Metals Neutral
SkinBioTherapeutics Neutral

Talisman Metals has a net margin of 0.00% compared to SkinBioTherapeutics' net margin of -8.73%. Talisman Metals' return on equity of 0.00% beat SkinBioTherapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Talisman MetalsN/A N/A 3.70%
SkinBioTherapeutics -8.73%-5.25%-61.18%

1.4% of Talisman Metals shares are held by institutional investors. Comparatively, 3.5% of SkinBioTherapeutics shares are held by institutional investors. 95.2% of Talisman Metals shares are held by insiders. Comparatively, 2.7% of SkinBioTherapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Talisman Metals has higher earnings, but lower revenue than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Talisman MetalsN/AN/A-£1.35M£12.390.73
SkinBioTherapeutics£5.23M2.73-£3.71M-£0.16N/A

Summary

Talisman Metals beats SkinBioTherapeutics on 8 of the 10 factors compared between the two stocks.

How does Talisman Metals compare to Oxford BioDynamics?

Oxford BioDynamics (LON:OBD) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, media sentiment, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Talisman Metals has lower revenue, but higher earnings than Oxford BioDynamics. Oxford BioDynamics is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford BioDynamics£1.20M12.26-£103.52M-£0.20N/A
Talisman MetalsN/AN/A-£1.35M£12.390.73

In the previous week, Oxford BioDynamics had 1 more articles in the media than Talisman Metals. MarketBeat recorded 1 mentions for Oxford BioDynamics and 0 mentions for Talisman Metals. Oxford BioDynamics' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Oxford BioDynamics Neutral
Talisman Metals Neutral

11.7% of Oxford BioDynamics shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 47.0% of Oxford BioDynamics shares are owned by insiders. Comparatively, 95.2% of Talisman Metals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Talisman Metals has a net margin of 0.00% compared to Oxford BioDynamics' net margin of -825.61%. Talisman Metals' return on equity of 0.00% beat Oxford BioDynamics' return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford BioDynamics-825.61% -451.74% -56.23%
Talisman Metals N/A N/A 3.70%

Oxford BioDynamics has a beta of 0.42, meaning that its share price is 58% less volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, meaning that its share price is 10% less volatile than the broader market.

Summary

Talisman Metals beats Oxford BioDynamics on 8 of the 11 factors compared between the two stocks.

How does Talisman Metals compare to Fusion Antibodies?

Fusion Antibodies (LON:FAB) and Talisman Metals (LON:TLM) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

Talisman Metals has lower revenue, but higher earnings than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Talisman Metals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fusion Antibodies£2.11M5.93-£4.10M-£1.00N/A
Talisman MetalsN/AN/A-£1.35M£12.390.73

In the previous week, Fusion Antibodies' average media sentiment score of 0.00 equaled Talisman Metals'average media sentiment score.

Company Overall Sentiment
Fusion Antibodies Neutral
Talisman Metals Neutral

7.6% of Fusion Antibodies shares are owned by institutional investors. Comparatively, 1.4% of Talisman Metals shares are owned by institutional investors. 6.4% of Fusion Antibodies shares are owned by insiders. Comparatively, 95.2% of Talisman Metals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Talisman Metals has a net margin of 0.00% compared to Fusion Antibodies' net margin of -54.45%. Talisman Metals' return on equity of 0.00% beat Fusion Antibodies' return on equity.

Company Net Margins Return on Equity Return on Assets
Fusion Antibodies-54.45% -97.87% -63.78%
Talisman Metals N/A N/A 3.70%

Fusion Antibodies has a beta of 1.244, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Talisman Metals has a beta of 0.9, meaning that its stock price is 10% less volatile than the broader market.

Summary

Talisman Metals beats Fusion Antibodies on 7 of the 10 factors compared between the two stocks.

Get Talisman Metals News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLM vs. The Competition

Export
MetricTalisman MetalsBiotechnology IndustryHealthcare SectorLON Exchange
Market Cap£5.78M£3.88B£7.25B£2.80B
Dividend Yield0.83%3.65%2.52%6.26%
P/E Ratio0.7313.03275.44366.78
Price / SalesN/A1,148.01562.0588,865.26
Price / Cash1.00118.5077.1627.85
Price / Book3.7316.7510.647.07
Net Income-£1.35M-£22.65M£3.49B£5.89B
7 Day PerformanceN/A-4.89%-3.21%0.25%
1 Month Performance20.00%-12.84%-7.65%-0.03%
1 Year PerformanceN/A7.43%2.92%22.90%

Talisman Metals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLM
Talisman Metals
N/AGBX 9
+5.9%		N/AN/A£5.78MN/A0.735
AOR
AorTech International
N/AN/AN/AN/A£19.99M£539KN/A3
IXI
IXICO
N/AGBX 8.20
+5.8%		N/A-37.1%£17.95M£7.28MN/A79
SBTX
SkinBioTherapeutics
N/AGBX 5.20
-2.6%		N/A-61.8%£13.84M£5.23MN/A11
OBD
Oxford BioDynamics
N/AGBX 0.10
-2.9%		N/A-80.7%£13.71M£1.20MN/A45

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TLM) was last updated on 10/14/2026 by MarketBeat.com Staff.
From Our Partners
The AI Infrastructure Play Kevin O'Leary Is Backing
Kevin O'Leary became a strategic investor in a NASDAQ-listed AI infrastructure company, calling it essentially...
The Tomorrow Investor | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
Wall Street legend reveals his top AI stock before Oct. 20
Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...
Chaikin Analytics | Sponsoredtc pixel
The Iran War Isn’t Chaos. It’s Strategy.
Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...
Behind the Markets | Sponsoredtc pixel
AI Microcap Teams With Gentex on Next-Gen Military Helmets
Morgan Stanley projects the humanoid robotics market could reach $5 trillion by 2050, with more than 1 billion...
Capital Trends | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
Docket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...
Weiss Ratings | Sponsoredtc pixel
Trump's crypto bank just got approved
Last month I told investors that a Trump-backed crypto bank could be approved any day. On August 14, it was...
Crypto 101 Media | Sponsoredtc pixel